Recent studies suggest substantial interactions between opioids and et
hanol (EtOH). Both in vivo and in vitro experiments indicate that EtOH
can regulate opioid systems and that opioids can modify EtOH consumpt
ion. In the present studies, we examined if EtOH consumption altered o
pioid receptors and the potency of opioid analgesics. Mice were given
unlimited access to 6-7% EtOH alone for 7 days or were allowed to drin
k increasing concentrations (3-6%) of EtOH over 13-14 days. Controls h
ad access to water. The EtOH groups drank significantly less volume th
an controls, although there were no significant differences in body we
ight or baseline nociception. The analgesic (tail nick) potency of SC
morphine was decreased by similar to 1.6-2.0-fold in EtOH-treated mice
. A single acute dose of EtOH (1 g/kg) that produced blood alcohol lev
els in excess of that for 7 day exposure to EtOH, did not change morph
ine's analgesic ED50, suggesting that chronic exposure to EtOH was nec
essary for the reduction in potency. The change in morphine potency wa
s not due to pharmacokinetic differences because EtOH consumption did
not modify the concentration of morphine in brain and spinal cord. The
analgesic potency of a delta-opioid receptor agonist (ICV DSLET) was
also decreased by similar to 2-fold. Saturation binding studies indica
ted no changes in the density or affinity of brain and spinal cord del
ta-opioid ([H-3]DPDPE, [H-3]DSLET, [H-3]DeltorphinII) and mu-opioid ([
H-3]DAMGO) receptors. Similarly, there was no significant effect of Et
OH on delta-opioid receptor mRNA in either brain or spinal cord prepar
ations. Taken together, these data suggest that EtOH consumption decre
ases the analgesic potency of opioids in mice through a mechanism that
is unrelated to pharmacokinetics or opioid receptor changes in brain
and cord. (C) 1997 Elsevier Science Inc.